Literature DB >> 15255080

Diagnosis and treatment of levothyroxine pseudomalabsorption.

D J Lips1, M T van Reisen, V Voigt, W Venekamp.   

Abstract

Many causes of malabsorption of levothyroxine in patients with hypothyroidism have been thoroughly described in literature. Pseudomalabsorption, poor compliance of the patient with the therapy regime, is the most common cause of failure of levothyroxine therapy. Pseudomalabsorption is characterised by a deficient diagnostic process, patient denial and difficulties in treatment. The present article provides guidelines in diagnosing and treating pseudomalabsorption in hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255080

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  21 in total

1.  Treatment-refractory hypothyroidism.

Authors:  Abdulaziz Ramadhan; Michael Tamilia
Journal:  CMAJ       Date:  2011-12-12       Impact factor: 8.262

2.  Pseudomalabsorption of Levothyroxine: A Challenge for the Endocrinologist in the Treatment of Hypothyroidism.

Authors:  Nancy Van Wilder; Bert Bravenboer; Sarah Herremans; Nathalie Vanderbruggen; Brigitte Velkeniers
Journal:  Eur Thyroid J       Date:  2016-11-24

Review 3.  The emergence of levothyroxine as a treatment for hypothyroidism.

Authors:  James V Hennessey
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

4.  Chiropractic Management of a Patient With Chronic Fatigue: A Case Report.

Authors:  Christopher T Arick
Journal:  J Chiropr Med       Date:  2016-10-18

5.  Treatment of refractory and severe hypothyroidism with sublingual levothyroxine in liquid formulation.

Authors:  Carmela Peirce; Serena Ippolito; Alejandra Lanas; Marcella Pesce; Gilda Pontieri; Debora Arpaia; Giovanni Sarnelli; Bernadette Biondi
Journal:  Endocrine       Date:  2017-07-13       Impact factor: 3.633

6.  Levothyroxine pseudo-malabsorption: testing and treatment in the outpatient setting.

Authors:  Grzegorz M Rdzak; Laura M Whitman; Silvio E Inzucchi
Journal:  Ther Adv Endocrinol Metab       Date:  2018-04-28       Impact factor: 3.565

7.  Thyroxine softgel capsule in patients with gastric-related T4 malabsorption.

Authors:  Maria Giulia Santaguida; Camilla Virili; Susanna Carlotta Del Duca; Miriam Cellini; Ilenia Gatto; Nunzia Brusca; Corrado De Vito; Lucilla Gargano; Marco Centanni
Journal:  Endocrine       Date:  2015-01-17       Impact factor: 3.633

8.  Levothyroxine absorption test results in patients with TSH elevation resistant to treatment.

Authors:  Ilgin Yildirim Simsir; Utku Erdem Soyaltin; Ahmet Gokhan Ozgen
Journal:  Endocrine       Date:  2019-03-13       Impact factor: 3.633

Review 9.  Thyroid hormone therapy for hypothyroidism.

Authors:  Bernadette Biondi; David S Cooper
Journal:  Endocrine       Date:  2019-08-01       Impact factor: 3.633

10.  Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation.

Authors:  Silvia Morelli; Gianpaolo Reboldi; Sonia Moretti; Elisa Menicali; Nicola Avenia; Efisio Puxeddu
Journal:  Endocrine       Date:  2015-11-04       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.